Literature DB >> 12134966

Quantitative assessment of chimeraplast stability in biological fluids by polyacrylamide gel electrophoresis and laser-assisted fluorescence analysis.

David de Semir1, Anna Avinyó, Sara Larriba, Virginia Nunes, Teresa Casals, Xavier Estivill, Josep M Aran.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12134966     DOI： 10.1023/a:1016133722394

Source DB:  PubMed          Journal:  Pharm Res        ISSN： 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  14 in total

Review 1.  The potential of nucleic acid repair in functional genomics.

Authors:  M C Rice; K Czymmek; E B Kmiec
Journal:  Nat Biotechnol       Date:  2001-04       Impact factor: 54.908

Review 2.  Antisense therapeutics: is it as simple as complementary base recognition?

Authors:  S Agrawal; E R Kandimalla
Journal:  Mol Med Today       Date:  2000-02

Review 3.  Targeted gene correction: a new strategy for molecular medicine.

Authors:  S Ye; A C Cole-Strauss; B Frank; E B Kmiec
Journal:  Mol Med Today       Date:  1998-10

4.  Vitravene--another piece in the mosaic.

Authors:  S T Crooke
Journal:  Antisense Nucleic Acid Drug Dev       Date:  1998-08

Review 5.  Therapeutic repair of mutated nucleic acid sequences.

Authors:  T M Woolf
Journal:  Nat Biotechnol       Date:  1998-04       Impact factor: 54.908

Review 6.  Triplex DNA: fundamentals, advances, and potential applications for gene therapy.

Authors:  P P Chan; P M Glazer
Journal:  J Mol Med (Berl)       Date:  1997-04       Impact factor: 4.599

7.  Polyethylenimine but not cationic lipid improves antisense activity of 3'-capped phosphodiester oligonucleotides.

Authors:  S Dheur; N Dias; A van Aerschot; P Herdewijn; T Bettinger; J S Rémy; C Hélène; E T Saison-Behmoaras
Journal:  Antisense Nucleic Acid Drug Dev       Date:  1999-12

Review 8.  Oligonucleotide N3'-->P5' phosphoramidates as potential therapeutic agents.

Authors:  S M Gryaznov
Journal:  Biochim Biophys Acta       Date:  1999-12-10

9.  A controlled, Phase 1 clinical trial to evaluate the safety and effects in HIV-1 infected humans of autologous lymphocytes transduced with a ribozyme that cleaves HIV-1 RNA.

Authors:  F Wong-Staal; E M Poeschla; D J Looney
Journal:  Hum Gene Ther       Date:  1998-11-01       Impact factor: 5.695

10.  Different frequency of gene targeting events by the RNA-DNA oligonucleotide among epithelial cells.

Authors:  E Santana; A E Peritz; S Iyer; J Uitto; K Yoon
Journal:  J Invest Dermatol       Date:  1998-12       Impact factor: 8.551
View more
  1 in total

Review 1.  Oligo/polynucleotide-based gene modification: strategies and therapeutic potential.

Authors:  R Geoffrey Sargent; Soya Kim; Dieter C Gruenert
Journal:  Oligonucleotides       Date:  2011-03-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.